Certara IQ FIH Workflow | Model-Informed First-In-Human Dose Prediction
Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating clinical readiness and regulatory confidence.| Certara
Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide safer, more effective drug development decisions. The post Key Lessons & Opportunities in applying NCA and PopPK to ADCs appeared first on Certara.| Certara
QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges & path toward broader impact in drug development. The post Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling appeared first on Certara.| Certara
[event_date_range] The post AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success appeared first on Certara.| Certara
Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating clinical readiness and regulatory confidence.| Certara
